Zilli, ThomasDirix, PietHeikkilä, ReinoLiefhooghe, NickSiva, ShankarGómez Iturriaga, AlfonsoEveraerts, WouterOtte, François XavierCouñago Lorenzo, FelipeOst, PietEt al.2023-07-312023-07-312021Zilli, T., Dirix, P., Heikkilä, R., Liefhooghe, N., Siva, S., Gómez-Iturriaga, A., Everaerts, W., Otte, F., Shelan, M., Mercier, C., Achard, V., Thon, K., Stellamans, K., Moon, D., Conde-Moreno, A., Papachristofilou, A., Scorsetti, M., Gückenberger, M., Ameye, F., Zapatero, A., … Ost, P. (2021). The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. European Urology Focus, 7(2), 241–244. https://doi.org/10.1016/j.euf.2020.12.0102405-4569http://hdl.handle.net/11268/12251Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.engNeoplasias de la próstataTerapia recuperativajournal article10.1016/j.euf.2020.12.010restricted accessCáncerActividad científicaTratamiento médico